- $49.14bn
- $57.58bn
- $7.40bn
- 86
- 25
- 93
- 77
Annual income statement for Nasdaq, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,627 | 5,886 | 6,226 | 6,064 | 7,400 |
| Cost of Revenue | |||||
| Gross Profit | 2,903 | 3,420 | 3,582 | 3,895 | 4,649 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 4,393 | 4,361 | 4,662 | 4,486 | 5,602 |
| Operating Profit | 1,234 | 1,525 | 1,564 | 1,578 | 1,798 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,212 | 1,534 | 1,475 | 1,401 | 1,449 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 933 | 1,187 | 1,123 | 1,057 | 1,115 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 933 | 1,187 | 1,125 | 1,059 | 1,117 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 933 | 1,187 | 1,125 | 1,059 | 1,117 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.25 | 2.53 | 2.41 | 2.38 | 1.94 |
| Dividends per Share |